Ambrisentan
Active substance: ambrisentan
TABLET, FILM COATED · AMBRISENTAN 5 mg/1
United StatesActive
Marketing holder: Mylan Pharmaceuticals Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- AMBRISENTAN · 5 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 3 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-abed-7cfd-9383-0a747ea9fc70,01a1208c-b3bc-7d68-8cdd-c333239f9687,01a1208c-bb3e-7e95-a488-f896d78443b7,01a1208c-d391-7f59-9d87-dde32e80bd4a,01a1208d-2e45-7678-9cae-a77d55146d86;count=26 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0378-4270
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 0378-4270 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0378-4270 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0378-4270 · Verified 2026-10-09 · open in source